Elekta of Stockholm, Sweden, has installed its Elekta Neuromag system for the investigation of autism at the newly opened Oxford Neurodevelopmental Magnetoencephalography Centre.
Elekta's Neuromag technology is designed for the noninvasive diagnosis and treatment of brain disorders through magnetoencephalography (MEG).
The facility, located at the University Department of Psychiatry at Warneford Hospital in Oxford, U.K., was built specifically for the study and research of autism and other neurodevelopmental disorders.
By AuntMinnie.com staff writers
October 12, 2007
Related Reading
Elekta receives Austrian contract, September 28, 2007
Elekta receives Italian orders, September 25, 2007
Elekta inks deal with St. Louis health network, September 6, 2007
Johns Hopkins to buy Elekta Synergy system, August 17, 2007
Barnes-Jewish orders Elekta gamma knife, August 14, 2007
Copyright © 2007 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
